Zoledronic acid more commonly known as Reclast, Aclasta or Zometa. This medication works by slowing down osteoclast i.e. bone cells. These osteoclasts generally break down the hard-mineral structure of the bones in order to keep the bones healthy. But when the prostate cancer spreads to bones, these osteoclasts become ...
Read More
Most women diagnosed in the early stages of breast cancer are likely to have a great prognosis. It is also likely that they remain disease free for several years after their treatment ends. ...
Read More
Renal Cell Cancer or Renal Cell Carcinoma or RCC is the most common form of kidney cancer that is diagnosed in adults. RCC is fast growing and can often spread from the kidney to nearby organs. ...
Read More
What is Everolimus? Everolimus is a targeted therapy which blocks the spread and growth of cancer cells. Everolimus is the generic name for the medication Afinitor, which is manufactured by Novartis. ...
Read More
Bendamustine is used as an effective fir-line treatment for heavily pre-treated relapsed patients and multiple myeloma (MM) patients. The combination therapy of Treanda (generic Bendamustine) with other drugs like Rituximab are considered when all the other treatment options have been exhausted. ...
Read More
Bendamustine hydrochloride is a cytotoxic anti-cancer medication approved by the FDA for the treatment of first line chronic lymphocytic leukemia and relapsed non-Hodgkin Lymphoma. It works by interefering with the cell replication by the double stranded DNA and cross linking single DNA. ...
Read More
Hepatocellular Carcinoma or HCC is the most common type of liver cancer and is responsible for over 90% of liver cancer deaths. It is estimated that 600,000 new cases of HCC are diagnosed annually which amounts to about 5% of all the cancer cases. ...
Read More
According to a new study, topotecan and Nexavar (generic Sorafenib) when combined, and there after used as a maintenance therapy has significantly improve the survival outcomes in women who are suffering from platinum-resistant ovarian cancer. ...
Read More
According to the Phase 2 of clinical trial, Nilotinib (Brand Tasigna) manufactured by Novartis can help in modulating the metabolism and level of dopamine in the body. Formation of toxic-alpha synuclein aggregates can also be prevented with the help Nilotinib (generic of Tasigna) treatment. ...
Read More
